These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9724074

  • 1. Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide.
    Krassas GE, Kaltsas TT, Pontikides N, Jacobs H, Blum W, Messinis I.
    Eur J Endocrinol; 1998 Aug; 139(2):184-9. PubMed ID: 9724074
    [Abstract] [Full Text] [Related]

  • 2. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
    Chapman IM, Wittert GA, Norman RJ.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [Abstract] [Full Text] [Related]

  • 6. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
    Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
    [Abstract] [Full Text] [Related]

  • 7. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [Abstract] [Full Text] [Related]

  • 11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 12. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP, Hatziioanidis AH, Trovas GP, Misichronis GS, Kounadi TG, Devetzaki OA, Andronis CK, Rangou DB, Chlouverakis CS.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [Abstract] [Full Text] [Related]

  • 13. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
    Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, Cimino V, Porcelli T, Romualdi D, Guido M, Lanzone A, Pontecorvi A, De Marinis L.
    J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 18. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
    Welt CK, Taylor AE, Martin KA, Hall JE.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
    [Abstract] [Full Text] [Related]

  • 19. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
    Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnston DG, Franks S.
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
    [Abstract] [Full Text] [Related]

  • 20. Leptin concentrations in the polycystic ovary syndrome.
    Mantzoros CS, Dunaif A, Flier JS.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1687-91. PubMed ID: 9177364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.